Healthcare utilization and costs of systemic lupus erythematosus in medicaid

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kan, Hong J ^a   Song, Xue ^b   Johnson, Barbara H ^b   Bechtel, Benno ^c   O'Sullivan, Donna ^b   Molta, Charles T ^a  

^a GLAXOSMITHKLINE   (United States)

^b IBM WATSON HEALTH   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; COST; ECONOMICS; FACTUAL DATABASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TIME; UNITED STATES;

ADULT; AGED; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAID; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84874622957     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/808391     Document Type: Article

References (19)

1. Agmon-Levin N., Mosca M., Petri M., Shoenfeld Y., Systemic lupus erythematosus one disease or many? Autoimmunity Reviews 2012 8 593 595
2. Helmick C. G., Felson D. T., Lawrence R. C., Gabriel S., Hirsch R., Kwoh C. K., Liang M. H., Kremers H. M., Mayes M. D., Merkel P. A., Pillemer S. R., Reveille J. D., Stone J. H., Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 2008 58 1 15 25 2-s2.0-38149138096 10.1002/art.23177
3. Naleway A., Davis M. E., Greenlee R. T., Wilson D. A., McCarty D. J., Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005 14 10 862 866 2-s2.0-27744565201 10.1191/0961203305lu2182xx (Pubitemid 41597626)
4. http://www.lupus.org/
5. Nichol M. B., Shi S., Knight T. K., Wallace D. J., Weisman M. H., Eligibility, utilization and costs in a California Medicaid lupus population. Arthritis Care and Research 2004 51 6 996 1003 2-s2.0-10644275193 10.1002/art.20819 (Pubitemid 39648194)
6. Murdaca G., Colombo B. M., Puppo F., Emerging biological drugs: a new therapeutic approach for systemic lupus erythematosus. An update upon efficacy and adverse events. Autoimmunity Reviews 2011 11 1 56 60 10.1016/j.autrev.2011. 07.006
7. Carls G., Li T., Panopalis P., Wang S., Mell A. G., Gibson T. B., Goetzel R. Z., Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis. Journal of Occupational and Environmental Medicine 2009 51 1 66 79 2-s2.0-66749176262 10.1097/JOM. 0b013e31818a405a
8. Li T., Carls G. S., Panopalis P., Wang S., Gibson T. B., Goetzel R. Z., Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population. Arthritis Care and Research 2009 61 6 755 763 2-s2.0-66749188301 10.1002/art.24545
9. Deyo R. A., Cherkin D. C., Ciol M. A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992 45 6 613 619 2-s2.0-0026639706 10.1016/0895-4356(92)90133-8
10. Ruperto N., Hanrahan L. M., Alarcón G. S., International census for a definition of disease flare in lupus. Lupus 2011 20 5 453 462 10.1177/0961203310388445
11. Gordon C., Sutcliffe N., Skan J., Stoll T., Isenberg D. A., Definition and treatment of lupus flares measured by the BILAG index. Rheumatology 2003 42 11 1372 1379 2-s2.0-0242524630 10.1093/rheumatology/keg382 (Pubitemid 37407029)
12. Garris C., Jhingran P., Engel-Nitz N. M., Assessing systematic Lupus erythematosus disease severity and disease flares: development of a claims-based algorithm. Proceedings of the ACR/ARHP Annual Scientific Meeting 2010 November 2010 Atlanta, Ga, USA
13. Engel-Nitz N., Burke J., Garris C., Jhingran P., Dennis G., Bass D., Distinguishing levels of disease flare in patients with systemic Lupus erythematosus using administrative claims data. Proceedings of the ACR/ARHP Annual Scientific Meeting 2010 November 2010 Atlanta, Ga, USA
14. Rosenbaum P. R., Rubin D. B., The central role of the propensity score in observational studies for causal effects. Biometrika 1983 70 1 41 55 2-s2.0-77951622706 10.1093/biomet/70.1.41
15. Ho D. E., Imai K., King G., Stuart E. A., Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis 2007 15 3 199 236 2-s2.0-34249885738 10.1093/pan/mpl013
16. SAS Institute, Cary, NC, USA
17. StataCorp LP, College Station, TX, USA
18. Zhu T. Y., Tam L. S., Li E. K., Cost-of-illness studies in systemic lupus erythematosus: a systemic review. Arthristis Care & Research 2011 63 5 751 760
19. Garris C., Jhingran P. M., Engel-Nitz N. M., Burke J., Wegner J., Dennis D., Bass D. L., Cost impact of lupus in a large US managed care health plan. Proceedings of the Annual European Congress of Rheumatology (EULAR '10) June 2010 Rome, Italy